Maria Salvadó Figueras Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders. Institutions of which they are part Postdoctoral researcher Peripheral Nervous System Vall Hebron Institut de Recerca Neurology General Hospital Email Maria Salvadó Figueras Email Institutions of which they are part Postdoctoral researcher Peripheral Nervous System Vall Hebron Institut de Recerca Neurology General Hospital Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders.
She works as a neurologist at the Neuromuscular and Rare Diseases Unit of Vall d'Hebron Hospital and as a researcher in the Peripheral Nervous System Disease Research Laboratory (VHIR), currently led by Dr. R. Juntas-Morales. The main lines of this research group are based on the identification of new biomarkers and genetic determinants in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), autoimmune myasthenia gravis (MG), and genetic-based myopathies and neuropathies. She is also one of the professionals in the European Network for Neuromuscular and Rare Diseases (EURO-NMD ERN) and the European Network for rare neurological diseases (ERN-RND). Hospital Vall d’Hebron is member of these ERNs. She is co-author of more than 20 peer-reviewed articles and in February 2020, she obtained her PhD title from the Autonomous University of Barcelona for her thesis entitled "Study of genetic factors that influence the familial and sporadic forms of myasthenia gravis autoimmune ”(Teseo, TDX). In 2013, she was awarded the Scientific Poster Award at the International Symposium for ALS (MNDA). She is a co-investigator for several grants, research projects and clinical trials, including FIS (Fondo de Investigación Sanitarias) and MINECO (Ministerio de Economía y Competitividad) grants. These grants are for studies of rare neurological diseases such as ALS, myasthenia gravis, familial amyloid polyneuropathy (Corino-Andrade disease), mitochondrial diseases and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Projects Genotipado de alta resolución de los genes HLA y análisis de su expresión en el SNC en Esclerosis Lateral Amiotrófica como factor de riesgo: Investigando la hipótesis neuroinflamatoria IP: José Manuel Vidal Taboada Collaborators: Maria Jose Herrero Mata, Maria Salvadó Figueras, Josep Gamez Carbonell, Arnau Llauradó Gayete Funding agency: Instituto de Salud Carlos III Funding: 117370 Reference: PI19/00593 Duration: 01/01/2020 - 30/06/2024 ANÁLISIS DE FACTORES GENETICOS DE SUSCEPTIBILIDAD Y MODIFICANTES DE FENOTIPO EN LAS FORMAS FAMILIARES Y ESPORADICAS DE MIASTENIA GRAVIS AUTOIMMUNE MEDIANTE TECNICAS DE SECUENCIACIÓN MASIVA IP: Josep Gamez Carbonell Collaborators: Gisela Gili Serrat, Maria Salvadó Figueras, Francesc Rudilla Salvador Funding agency: Instituto de Salud Carlos III Funding: 92565 Reference: PI16/01673 Duration: 01/01/2017 - 05/06/2020 Investigación del rol de los polimorfismos HLA-DRB1/DQB1 como factores genéticos de susceptibilidad para las formas esporádicas y familiares de la miastenia gravis autoinmune en una población española IP: Josep Gamez Carbonell Collaborators: Maria Salvadó Figueras, Francesc Rudilla Salvador Funding agency: Instituto de Salud Carlos III Funding: 75927.5 Reference: PI13/01272 Duration: 01/01/2014 - 31/12/2016 Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis.(ITL) Codi Protocol: MG2012PREP IP: Josep Gamez Carbonell Collaborators: Maria Salvadó Figueras Funding agency: CSL Behring LLC Funding: 176819.76 Reference: ITL_CSL-ILA2011 Duration: 26/07/2012 - 31/12/2016 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page »
